Oklahoma Cancer Medical Imaging Center
Official title: Oklahoma Center of Medical Imaging for Translational Cancer Research
Funded at University of Oklahoma · NIH-11256725 · Data updated 2026-11-12
This effort creates a center to develop advanced imaging tools and predictive markers to help people with cancer get more personalized screening, diagnosis, and treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma NIH-funded |
| Lab location | 1 site (Norman, United States) |
| Project start | February 15, 2022 |
| Project end | December 31, 2026 |
| Funding year | 2026 |
| Award (this year) | $2,262,180 |
| NIH project number | 5P20GM135009-05 |
| Project ID | NIH-11256725 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates would be people with cancer who can participate in pilot imaging studies or who receive care through the University of Oklahoma clinics collaborating with the center.
✕Less likely to help
People without cancer, those who cannot travel to Oklahoma, or patients needing immediate standard-of-care treatment may not directly benefit since the center primarily supports research and development.
What this research studies
You would be hearing about a new medical imaging center at the University of Oklahoma that brings engineers and clinicians together to translate imaging advances into cancer care. The center will provide equipment, mentoring, and pilot studies to help junior investigators test new imaging technologies and quantitative markers. Work will span lab development, analysis of imaging measurements, and early tests that could include patient imaging or human-derived samples. The goal is to move promising imaging methods toward use in predicting risk, finding cancer earlier, and guiding treatment choices.
Why it matters
Potential benefit: If successful, this could lead to earlier detection and more precise, personalized cancer care for patients.
How similar studies have gone: Other translational imaging programs have produced useful diagnostic markers and guided clinical trials, though the specific technologies and quantitative markers here remain under active development.
Where this research is happening
-
University of Oklahoma
Norman, United States Active
Researchers
- Principal investigator: Jo, Javier Antonio — University of Oklahoma
- Study coordinator: Jo, Javier Antonio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.